Orca Bio

Medical Science Liaison

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

Candidates should possess a Doctor of Medicine (MD) or Doctor of Osteopathic Medicine (DO) degree, or a PharmD degree with relevant clinical experience, and a strong understanding of oncology and hematology. A minimum of 5 years of experience in a medical affairs role, particularly with cell therapies or stem cell transplantation, is required. Excellent communication and interpersonal skills are essential, along with the ability to travel up to 50% of the time.

Responsibilities

The Medical Science Liaison will identify, develop, and maintain relationships with key opinion leaders and healthcare providers, serving as a critical link between Orca Bio and external stakeholders. They will prepare and manage a territory management plan, engage with the Orca Pod field team, and develop a deep understanding of relevant studies and diseases. The MSL will actively assess the medical landscape through meetings with thought leaders, facilitating compliant scientific exchange, and ensuring patients have access to Orca Bio medicines for safe and appropriate use.

Skills

Scientific knowledge in hematology
Oncology
Blood cancers
Stem cell transplantation
Cell therapies
Relationship building with KOLs
Communication skills
Presentation skills
Travel management

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Key Metrics

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI